Abstract
This review summarizes techniques, indications and contraindications for radiotherapy for non-melanoma skin cancer. Different radiotherapy techniques including brachytherapy, electron treatments, photon treatments with electronic brachytherapy, linear accelerator, and orthovoltage machines are available. Radiation oncologists have to select the best technique for different sites and scenarios. Details of specific radiotherapeutic preparation and clinical care discussed in this review will be of great help to the reader at the point of care.
Keywords: Intensity-modulated radiotherapy, linear accelerator, othovoltage, skin tumor, superficial xray, treatment, Xoft.
Current Cancer Therapy Reviews
Title:Radiotherapy for Non-Melanoma Skin Cancer
Volume: 12 Issue: 2
Author(s): Khanh Vu, Patricia Tai and Joseph S.K. Au
Affiliation:
Keywords: Intensity-modulated radiotherapy, linear accelerator, othovoltage, skin tumor, superficial xray, treatment, Xoft.
Abstract: This review summarizes techniques, indications and contraindications for radiotherapy for non-melanoma skin cancer. Different radiotherapy techniques including brachytherapy, electron treatments, photon treatments with electronic brachytherapy, linear accelerator, and orthovoltage machines are available. Radiation oncologists have to select the best technique for different sites and scenarios. Details of specific radiotherapeutic preparation and clinical care discussed in this review will be of great help to the reader at the point of care.
Export Options
About this article
Cite this article as:
Vu Khanh, Tai Patricia and Au S.K. Joseph, Radiotherapy for Non-Melanoma Skin Cancer, Current Cancer Therapy Reviews 2016; 12 (2) . https://dx.doi.org/10.2174/1573394712666161018113857
DOI https://dx.doi.org/10.2174/1573394712666161018113857 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Green Approaches for Cancers Management: An Effective Tool for Health Care
Anti-Cancer Agents in Medicinal Chemistry The Caveolin-1 Connection to Cell Death and Survival
Current Molecular Medicine Basic and Clinical Aspects of Gene Therapy for Retinopathy Induced by Diabetes
Current Gene Therapy A Review of Pharmacological Treatment Options for Lung Cancer: Emphasis on Novel Nanotherapeutics and Associated Toxicity
Current Drug Targets Chlorophylls and their Derivatives Used in Food Industry and Medicine
Mini-Reviews in Medicinal Chemistry In Silico and Biochemical Analyses Identify Quinone Reductase 2 as a Target of Piceatannol
Current Medicinal Chemistry Cancer Therapy: Targeting Cell Cycle Regulators
Anti-Cancer Agents in Medicinal Chemistry The Pros and Cons of Targeting Protein Kinase c (PKC) in the Management of Cancer Patients
Current Pharmaceutical Biotechnology Copper Complexes as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Glycyrrhetinic Acid and Its Derivatives: Anti-Cancer and Cancer Chemopreventive Properties, Mechanisms of Action and Structure- Cytotoxic Activity Relationship
Current Medicinal Chemistry Resveratrol, a Phytochemical Inducer of Multiple Cell Death Pathways: Apoptosis, Autophagy and Mitotic Catastrophe
Current Medicinal Chemistry c-Myc and Downstream Targets in the Pathogenesis and Treatment of Cancer
Recent Patents on Anti-Cancer Drug Discovery Phosphonic Esters and their Application of Protease Control
Current Pharmaceutical Design Functional Genome and Proteome Analyses of Cutaneous Autoimmune Diseases
Current Pharmaceutical Design Review on Triggered Liposomal Drug Delivery with a Focus on Ultrasound
Current Cancer Drug Targets DNA Binding Mode of Transition Metal Complexes, A Relationship to Tumor Cell Toxicity
Current Medicinal Chemistry 9th International Meeting on Metabotropic Gglutamate Receptors (Taormina, Sicily, October 1-6, 2017).
Current Neuropharmacology Clear Cell Renal Cell Cancer Tumor-Propagating Cells: Molecular Characteristics
Current Signal Transduction Therapy The Role of CXC-Chemokine IL-8, IL-6 and CXCR2 Receptor in Lymphoplasmacytic Lymphoma: Correlations with Microvascular Characteristics and Clinical Features
Current Angiogenesis (Discontinued) Local Gene Delivery for Cancer Therapy
Current Gene Therapy